Cancer

Coreline Soft Unveils AVIEW 2.0 at RSNA 2025: Next-Generation AI Platform Redefining Radiology Workflow Standards

CHICAGO and SEOUL, South Korea, Nov. 7, 2025 /PRNewswire/ -- Coreline Soft will introduce its groundbreaking chest AI platform AVIEW 2.0…

2 months ago

‘Coffee Diplomacy’ at APEC: Korea-U.S. Startup Imunika Goes Viral as Japan’s Motegi Prepares Tariff Talks with Trump

Japan's  newly appointed Foreign Minister Toshimitsu Motegi sparked an unexpected viral moment at APEC 2025 after stopping by Imunika —…

2 months ago

Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762

Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)King of Prussia, Pennsylvania--(Newsfile Corp. -…

2 months ago

Establishment Labs to Present at Jefferies London Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

2 months ago

Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie

Net proceeds will be applied to debt reduction, advancing Organon’s ongoing deleveraging efforts Positions Organon for future investment in growth…

2 months ago

Tizona Therapeutics Presents Clinical Translational Evidence of Dual Innate and Adaptive Immune Activation with TTX-080, a First-in-Class HLA-G Antagonist, in Patients with Advanced Solid Tumors at SITC 2025

Enrolling patients in ongoing randomized Phase 1b trial in MSS metastatic colorectal cancer, evaluating TTX-080 in combination with cetuximab +…

2 months ago

Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program

King of Prussia, Pennsylvania--(Newsfile Corp. - November 7, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company…

2 months ago

Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence

The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one…

2 months ago

Lumonus Raises A$25 Million in Series B to Scale AI Powered Oncology Workflows Globally

SYDNEY, Nov. 6, 2025 /PRNewswire/ -- Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close…

2 months ago

Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden

WASHINGTON, Nov. 6, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people…

2 months ago